Sjögren’s disease achieves the rheumatologic trifecta of a clinically driven diagnosis, heterogenous manifestations and no broadly approved treatments. Justification for the use of outside diagnostic testing—or worse, invasive minor salivary gland biopsy—for a skeptical patient being managed symptomatically requires a certain level of explanatory jujitsu. After more than a decade of glimpses of promising treatments that disappeared on closer inspection, we now have a handful of increasingly evidence-based treatments and recalibrated tools for measuring success. See the articles below for updates on this challenging condition.
FEATURED ARTICLE: New Discoveries in Sjögren’s Disease